No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CNS240517C80000
- 0.75
- 0.000.00%
15min DelayClose May 15 15:58 ET
0.75High0.75Low
0.75Open0.75Pre Close1 Volume0 Open Interest80.00Strike Price75.00Turnover120.42%IV9.27%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.75Time Value100Contract SizeAmericanOptions Type0.2061Delta0.0423Gamma98.53Leverage Ratio-0.4645Theta0.0008Rho20.31Eff Leverage0.0160Vega
Intraday
- 5D
- 1D
News
Cohen & Steers Announces Additional Changes to Realty Indexes
Cohen & Steers, Inc. (NYSE: CNS) announced today additional pending changes to its Realty Majors Indexes, effective as of the close of business on...
Cohen & Steers Announces Changes to Realty Indexes
NEW YORK, May 13, 2024—Cohen & Steers, Inc. (NYSE: CNS) announced today a change to its Realty Majors Portfolio Index (RMP) capitalization policy. Currently, individual index constituent capitalizatio
Cohen & Steers Files to Sell 21.1M Shares
Express News | Cohen & Steers Inc May Offer From Time To Time Shares Of Common Stock In One Or More Offerings; Selling Stockholders May Offer From Time To Time Up To 21.1M Shares Of Common Stock In One Or More Offerings
Express News | Cohen & Steers Inc - May Offer From Time to Time Shares of Common Stock in One or More Offerings
Cohen & Steers April AUM Dented by Market Depreciation, Net Outflows
Comments
Investor concerns grow over Cohen & Steers' high P/E ratio in relation to dwindling earnings and low predicted growth rate. Speculations suggest the excessive P/E ratio is driven by investor confidence in a business turnaround which may not be sustainable given current earnings and growth rates.
Cohen & Steers, Inc.'s (NYSE:CNS) Business Is Yet to Catch Up With Its Share PriceAn insider selling shares at a price lower than market value could reflect their belief in a fair lower price. Absence of purchases in the past year despite high insider ownership might cause concern. Usually, however, a high level of insider ownership is seen positively as it implies management's alignment with shareholder interests.
Gapping up
In reaction to earnings/guidance:
• $New Relic(NEWR.US$ +3.8% (guidance), $American Airlines(AAL.US$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
In reaction to earnings/guidance:
• $New Relic(NEWR.US$ +3.8% (guidance), $American Airlines(AAL.US$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
6
Read more